José Antonio Mesa
Serbia and Montenegro
Mr. Mesa is the Chief Investment Officer at Caixa Capital Risc. He specializes in investments in biotechnology and medical devices companies, where he is responsible for dealflow. He currently serves on the Board of Directors at Genmedica Therapeutics, Omnia Molecular, Sanifit and MedLumics. His experience began in the Department of Business Development at Genzyme Corporation. He later joined the Technology Portfolio team at Genoma España, a public sector foundation that promotes technology development, knowledge transfer and innovation in the biotechnology sector, where he specialized in the analysis of investment opportunities in start-up companies. He holds a degree in Biology and a Masters in Corporate Finance from the University Complutense of Madrid and a PDD from IESE (Barcelona).
Medicine,Medical Devices,Biology, Biotechnology